Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIM.L Regulatory News (SIM)

  • There is currently no data for SIM

Holding(s) in Company

5 Oct 2016 07:00

RNS Number : 6984L
SimiGon Limited
05 October 2016
Β 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

Β 

Β 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Β 

Simigon Ltd IL0010991185

2 Reason for the notification (please tick the appropriate box or Β boxes):

An acquisition or disposal of voting rights

Β 

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are Β attached

Β 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

Β 

An event changing the breakdown of voting rights

Β 

Other (please specify):

Β 

Β 

3. Full name of person(s) subject to the notification obligation: iii

Β 

Β 

AXXION S.A.

Β 

4. Full name of shareholder(s)

(if different from 3.):iv

Β 

5. Date of the transaction and date on which the threshold is crossed or reached: v

Β 

30th September 2016

6. Date on which issuer notified:

4th October 2016

7. Threshold(s) that is/are crossed or reached: vi, vii

Β 

Crossing above 5%

Β Β Β Β 

Β 

8. Notified details:

A: Voting rights attached to shares viii, Β ix

Class/type of shares

Β 

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering Β transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Β 

Β 

IL0010991185

Β 

Β 

2.250.000

Β 

Β 

2.250.000

Β 

Β 

3.500.000

Β 

Β 

3.500.000

Β 

Β 

Β 

6.81

Β 

Β 

B: Qualifying Financial Instruments

Resulting situation after the triggering Β transaction

Type of financial

Expiration

Exercise/

Number of voting

% of voting

instrument

date xiii

Conversion Period xiv

rights that may be

rights

acquired if the

instrument is

exercised/ converted.

Β 

N/A

Β 

Β 

Β 

Β 

Β 

C: Financial Instruments with similar economic effect to Qualifying Financial Β Instruments

xv, xvi

Resulting situation after the triggering Β transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Β 

N/A

Β 

Β 

Β 

Β 

Nominal

Delta

Β 

Β 

Β 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3.500.000

6.81%

Β 

Β Β 

Β 

Β Β 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Β 

AXXION S.A. holds these shares as legal representative for one of their unit trusts

Β 

Β 

Β 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

Β 

N/A

12. Date on which proxy holder will cease to hold voting rights:

Β 

N/A

Β 

Β 

Β 

13. Additional information:

Β 

AXXION S.A.

Β 

14. Contact name:

Heiko Hector Risk Management

Β 

15. Contact telephone number:

Β 

+352 / 76 94 94 - 567

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLBRBDGXDGBGLS
Date   Source Headline
4th Apr 20224:05 pmRNSMerger effective and Cancellation confirmed
28th Mar 20223:50 pmRNSUpdate related to Merger and Delisting schedule
28th Mar 20227:30 amRNSSuspension - SimiGon Limited
17th Mar 20227:00 amRNSUpdate on Merger & Cancellation timetable
3rd Mar 20227:00 amRNSUpdate to proposed Merger & Delisting
25th Feb 20222:15 pmRNSUpdate to proposed Merger & Delisting
18th Feb 20225:31 pmRNSResult of Special General Meeting of Shareholders
11th Feb 20226:26 pmRNSShareholder Update Re Tender Offer
3rd Feb 20223:00 pmRNSUpdate to Notice of Special General Meeting
17th Jan 20222:00 pmRNSPrice Monitoring Extension
14th Jan 202212:30 pmRNSProposed Merger & Delisting
30th Dec 20213:45 pmRNSResult of AGM
25th Nov 20217:00 amRNSNotice of AGM
5th Nov 20217:00 amRNSAppeal filed Against Court Ruling
5th Oct 20217:00 amRNSSimiGon wins U.S. Marine Corps Contract
27th Sep 20217:00 amRNSInterim Results
16th Aug 20217:00 amRNSSimiGon Re-awarded Blanket Purchase Agreement
9th Aug 20217:00 amRNSUSAF Extends SimiGon Inc. Support Contract
29th Jun 202111:05 amRNSPosting of Annual Report
15th Jun 202111:34 amRNSCourt Ruling in The Action for Prerogative Relief
28th Apr 20217:00 amRNSFinal Results
31st Mar 20217:00 amRNSTrading update
30th Dec 20202:44 pmRNSResult of AGM
21st Dec 20205:25 pmRNSHolding(s) in Company
23rd Nov 20204:46 pmRNSNotice of AGM
14th Oct 20204:49 pmRNSHolding(s) in Company
5th Oct 20208:15 amRNSSimiGon capitalize on investment in technology
25th Sep 20207:00 amRNSInterim Results
29th Jun 20207:00 amRNSPosting of Annual Report and Accounts
24th Jun 20204:40 pmRNSSecond Price Monitoring Extn
24th Jun 20204:35 pmRNSPrice Monitoring Extension
26th May 20207:00 amRNSSimiGon M&A team seeks strategic acquisitions
4th May 20207:00 amRNSUSAF extends SimiGon support contract
28th Apr 20207:00 amRNSFinal Results
16th Apr 20203:17 pmRNSResult of General Meeting
7th Apr 20203:57 pmRNSUpdate regarding forthcoming General Meeting
12th Mar 20201:00 pmRNSNotice of GM
9th Mar 20207:00 amRNSTrading Update
15th Jan 20207:00 amRNSNotice of Claim
30th Dec 20192:42 pmRNSResult of AGM
9th Dec 201912:32 pmRNSNotice of AGM - Replacement
2nd Dec 20199:32 amRNSSimiGon awarded $1.8m contract for C-130 VMT
22nd Nov 20197:00 amRNSNotice of AGM
7th Oct 20197:00 amRNSContract Win
30th Sep 20197:00 amRNSHalf-year Report
9th Sep 20197:00 amRNSContract Win
30th Aug 20197:00 amRNSExecutive Management & Directorate Change
22nd Aug 20197:00 amRNSSimigon awarded Blanket Purchase Agreement by USAF
12th Aug 20197:00 amRNSContract Win
12th Aug 20197:00 amRNSSuccessful Completion of Systems Delivery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.